Our 2025 Database of anti-CCR8 Therapeutic Programmes is available for free download here.
🔬 What’s inside?
✅ 10+ preclinical programmes
✅ 15+ clinical trials
✅ Diverse modalities: mAbs, bispecifics, CAR-T cells, ADCs, and small molecules
Featuring anti-CCR8 programmes from:
AbbVie, Abilita Therapeutics, Inc., Actinium Pharmaceuticals, Inc., Amgen, Bayer, BeiGene, BioNTech SE /Biotheus, Bristol Myers Squibb / ONO PHARMACEUTICAL CO., LTD., Chinese Academy of Sciences, Coherus Oncology / Surface Oncology, DOMAIN Therapeutics, Egle Therapeutics, FibroGen, Inc. / HiFiBiO Therapeutics, Genentech / Roche, Gilead Sciences / Jounce Therapeutics, Inc., Harbour BioMed, HC Biopharma, LaNova Medicines / Sino Biopharmaceutical Limited, Mabwell, Immunophage Biotech Co. Ltd., Oncurious NV, Qilu Pharmaceutical / Sound Biologics, Shionogi & Co., Ltd, Tiannuojiancheng Pharma InnoCare Pharma, University of Science and Technology of China, Zai Lab, Zelgen Biopharmaceuticals, and more!